Upadacitinib vs Adalimumab in PsA using RAPID3 Dr. Catherine Sims ( @DrCassySims) discusses abstract 0192 presented at #ACR22. 0192: Upadacitinib versus Adalimumab on Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with PsA, https://t.co/nRjgM45GdO https://t.co/MDqpW7ACXa